Home 5 Conditions 5 Glossopharyngeal Neuralgia

Neurovascular Compression

Glossopharyngeal Neuralgia

Severe, electric-shock pain in the throat, tongue or ear — rarer than trigeminal neuralgia, and highly treatable.

In brief

Brief attacks of stabbing pain in the throat, tongue, tonsil or ear
Caused by compression of the glossopharyngeal (ninth cranial) nerve
Often triggered by swallowing, talking or coughing
Diagnosis is clinical; MRI is used to exclude other causes
Treated with medication and, when needed, microvascular decompression

What is Glossopharyngeal Neuralgia?

Glossopharyngeal neuralgia (GPN) is a rare but extremely painful condition caused by abnormal irritation or compression of the glossopharyngeal nerve – the ninth cranial nerve – which carries sensation from the back of the throat, tongue, tonsils, and ear. It is characterised by sudden, severe, electric shock-like or stabbing pain in these areas, occurring in brief attacks that typically last from a few seconds to two minutes. GPN is significantly rarer than trigeminal neuralgia (which affects the face), occurring in approximately 0.7 per 100,000 people per year, accounting for approximately 1% of all cranial neuralgias. It is slightly more common on the left side, affects both sexes, and most commonly presents in adults over the age of 50, though can occur at any age. The vast majority of attacks are unilateral (one side only). Encouragingly, spontaneous remission — where the pain resolves on its own — occurs in a proportion of patients during follow-up, and only approximately 25% of patients ultimately require surgical treatment.

What Causes Glossopharyngeal Neuralgia?

In most cases, GPN is caused by a blood vessel — typically a branch of the posterior inferior cerebellar artery (PICA), anterior inferior cerebellar artery (AICA), or vertebral artery — pressing against the glossopharyngeal nerve where it exits the brainstem. This pulsatile compression irritates the nerve, lowering its threshold for firing and causing abnormal, involuntary pain signals. This is known as neurovascular conflict and is identical in principle to the mechanism causing trigeminal neuralgia and hemifacial spasm.

Less common causes include:

Tumours or cysts in the posterior fossa or at the base of the skull pressing on the nerve
Eagle’s syndrome — an abnormally elongated styloid bone in the neck causing direct nerve compression or irritation
Multiple sclerosis plaques involving the glossopharyngeal nerve nucleus in the brainstem
Infections, inflammatory conditions, or prior surgical scarring in the region of the nerve

In a small proportion of cases, no identifiable cause is found, and the condition is termed idiopathic GPN.

What are the Symptoms?

The pain of GPN is typically described as sudden, severe, stabbing, or electric shock-like in quality. It classically occurs in one or more of the following locations, which reflect the sensory distribution of the glossopharyngeal nerve:

The back of the throat and tonsil region
The back and base of the tongue
Deep inside the ear
The angle of the jaw or the side of the neck

Attacks are typically brief (seconds to two minutes), occur unpredictably, and are often triggered by:

Swallowing — the most common trigger, including both solids and liquids
Talking or laughing
Coughing or yawning
Chewing

In some patients, attacks are also accompanied by coughing and dysphonia (a hoarse or altered voice) occurring with the pain itself — distinct from the triggers listed above. Between attacks, most patients are pain-free, though some experience a low-grade aching discomfort in the affected area.

Vagoglossopharyngeal Neuralgia — An Important Variant

In a small but important subgroup of patients, pain attacks are accompanied by cardiac symptoms including a sudden slowing or momentary stopping of the heart (cardiac arrest or asystole), which can result in dizziness, fainting (syncope), and rarely convulsions. This occurs because the glossopharyngeal nerve has close connections with the vagus nerve, which controls heart rate. This variant is called vagoglossopharyngeal neuralgia and was well described in a landmark study of 217 cases by Rushton, Stevens and Miller. It requires prompt evaluation by both a neurosurgeon and a cardiologist. Any patient who faints or loses consciousness in association with their pain attacks should seek urgent medical attention.

What Conditions Can be Confused with Glossopharyngeal Neuralgia?

GPN is frequently misdiagnosed, often for months to years, due to its overlap with other conditions. Accurate diagnosis is essential as management differs significantly between conditions:

Trigeminal neuralgia — the most commonly confused condition; both cause brief, severe, electric shock-like pain, and both can cause pain felt in the ear, which is an area of overlap. Trigeminal neuralgia predominantly affects the face, jaw, and teeth, whereas glossopharyngeal neuralgia centres on the throat and base of the tongue. Rarely, both conditions can coexist in the same patient
Eagle’s syndrome — pain caused by an elongated styloid bone in the neck; can mimic GPN closely and is diagnosed on CT imaging
Superior laryngeal neuralgia — pain affecting the larynx and side of the throat due to irritation of a branch of the vagus nerve; distinguished by its location and trigger pattern
Temporomandibular joint (TMJ) dysfunction — jaw joint pain that can radiate to the ear but is typically constant, related to jaw movement, and associated with joint tenderness
Dental pain and tonsillar pathology — toothache, dental abscess, or tonsillar infection can cause throat and ear pain; typically more constant and associated with local inflammatory signs
Temporal arteritis (giant cell arteritis) — jaw and facial pain in older patients; distinguished by associated scalp tenderness, elevated inflammatory markers, and response to steroids
Otitis media or referred ear pain — pain within the ear caused by middle ear infection or Eustachian tube dysfunction

How is Glossopharyngeal Neuralgia Diagnosed?

GPN is a clinical diagnosis — it is made on the basis of the characteristic history of pain attacks and a careful examination. No single test confirms the diagnosis; rather, the investigations below are used to corroborate the clinical suspicion and exclude other conditions. A stepwise approach is used:

Clinical history and examination

The distribution and character of the pain, its triggers, and any associated symptoms (particularly syncope) are carefully documented. A thorough examination of the throat, tonsils, neck, and cranial nerves is performed. Laboratory tests including blood count, inflammatory markers, and metabolic panel are taken to exclude infection, inflammation, or malignancy.

Magnetic Resonance Imaging (MRI) and Angiography (MRA)

High-resolution MRI of the brain is the most important investigation. Specialised high resolution sequences (CISS or FIESTA), along with an MR angiogram (MRA), allow visualisation of the glossopharyngeal nerve at its exit zone from the brainstem, enabling identification of a compressing blood vessel. MRI also excludes other serious conditions such as posterior fossa tumours, multiple sclerosis or other structural causes. CT imaging may be added if Eagle’s syndrome is suspected, to evaluate the styloid bone.

Ear, Nose and Throat (ENT) Assessment

Assessment by an ear, nose and throat (ENT) surgeon should be undertaken in all patients. A careful examination of the throat, tonsils, larynx, and ear helps exclude local structural or inflammatory causes of the pain — including tumours, infection, and Eagle’s syndrome — and provides an important second specialist opinion. In diagnostically uncertain cases, temporary relief of pain following a local anaesthetic block of the glossopharyngeal nerve — usually performed by a pain specialist — can lend support to the diagnosis. This is a possibility only and not a routine part of the diagnostic work-up.

Cardiology Review

Patients with associated episodes of syncope, fainting, or cardiac irregularity require urgent cardiology assessment, including an electrocardiogram (ECG), echocardiogram, and ambulatory heart rate monitoring (Holter monitor).

How is Glossopharyngeal Neuralgia Treated?

There are three broad treatment strategies for GPN: medical management (medications), minimally invasive procedures, and surgery. Most patients initially respond well to medical management, with surgery reserved for those whose pain cannot be adequately controlled via medication.

Medical Management — First-Line Treatment

Medications are the first treatment offered to all patients with GPN. They do not treat the underlying nerve compression but can effectively control pain attacks in many patients, though GPN is typically less responsive to medication than trigeminal neuralgia.

Carbamazepine (Tegretol) is the most established first-line medication for GPN, and is the same drug used for trigeminal neuralgia. It works by stabilising abnormally excitable nerve membranes. It is typically started at a low dose and gradually increased until pain control is achieved. Common side effects include drowsiness, dizziness, and — particularly in elderly patients — low sodium levels in the blood. Blood tests are required to monitor for rare effects on blood counts and liver function. The starting dose is 100–200 mg per day, with gradual escalation to a typical maintenance dose of 400–800 mg per day in divided doses.
Oxcarbazepine (Trileptal) is a closely related medication that is often better tolerated than carbamazepine, with a lower risk of drug interactions. It is, however, considerably more expensive than carbamazepine, which is typically why carbamazepine remains the preferred first-line agent and oxcarbazepine reserved as an alternative.
Gabapentin (Neurontin) and Pregabalin (Lyrica) are anticonvulsant medications that are effective for neuropathic pain and are commonly used as alternatives or add-on therapy when carbamazepine provides inadequate relief or is not tolerated.
Other medications that may be helpful include lamotrigine, baclofen, amitriptyline, and phenytoin. These are typically used as second-line options or in combination with carbamazepine.

It is important to note that standard over-the-counter pain relievers such as paracetamol, ibuprofen, and aspirin are generally ineffective for GPN and are not recommended as primary treatment. The same applies to opioids — often the first medication given for severe pain in the emergency department — which are likewise ineffective for this neuropathic condition.

Minimally Invasive Procedures

For patients who do not tolerate medications well, or whose pain is only partially controlled, these minimally invasive pain procedures may be considered before surgery:

Glossopharyngeal nerve block involves a temporary injection of local anaesthetic — and sometimes a steroid — around the nerve, and can provide rapid, if short-lived, pain relief when oral medications are not yet adequate. It is performed as an outpatient procedure and may need to be repeated. It may occasionally also lend support to the diagnosis but is not a routine diagnostic test.
Percutaneous radiofrequency thermocoagulation (PRT) uses heat delivered through a needle to interrupt the nerve’s pain signals. It is occasionally considered in elderly or medically unfit patients who are unsuitable for surgery but is rarely required.
Pulsed radiofrequency ablation and stereotactic radiosurgery (Gamma Knife) are additional options that have been reported in small series, though evidence for these is more limited.

Surgical Treatment — Microvascular Decompression

Microvascular decompression (MVD) is the only treatment that directly addresses the underlying cause of GPN — the blood vessel compressing the glossopharyngeal nerve at the brainstem. It is the most effective and durable option and is the preferred surgical treatment for patients with confirmed neurovascular conflict on imaging.

The operation is performed under general anaesthetic and involves making a small opening in the skull behind the ear (a retrosigmoid craniotomy). Under a surgical microscope, the glossopharyngeal nerve at the brainstem is carefully identified and the offending blood vessel gently moved away from the nerve and held permanently in its new position via a few different techniques, relieving the compression and allowing the nerve to recover.

Long-term surgical outcome studies confirm MVD to be highly effective. Complete or near-complete pain relief is achieved in around 95% of patients and sustained over many years of follow-up, with only occasional recurrence requiring further surgery. The landmark series of 217 cases by Rushton, Stevens and Miller, and subsequent large surgical series, have consistently demonstrated excellent long-term outcomes for carefully selected patients.

MVD carries meaningful risks that must be carefully discussed before surgery. The most common complications include:

Temporary hoarseness or swallowing difficulty (dysphagia) — occurs in approximately one third of patients and resolves promptly in the majority of cases
Permanent damage to the glossopharyngeal nerve causing swallowing difficulty or taste changes — uncommon
Hearing deterioration — temporary in most cases; permanent hearing loss is rare
CSF leak — approximately 3%
Meningitis — less than 1%
Brainstem stroke — rare but serious

MVD should only be performed by a neurosurgeon with specific experience in posterior fossa and skull base surgery, at a centre with appropriate operative expertise and neurophysiological monitoring capability.

Glossopharyngeal Rhizotomy (Nerve Section)

Glossopharyngeal rhizotomy is performed as part of the same operation in selected situations — either when insufficient neurovascular conflict is found at surgery, or when the offending artery runs through the upper rootlets of the nerve and can only be moved away by cutting the uppermost rootlet. It is always carried out with neurophysiological monitoring of the lower cranial nerves, and may leave minor permanent numbness in the throat and occasional swallowing difficulties.

What Happens if Glossopharyngeal Neuralgia is Left Untreated?

GPN is not life-threatening in most cases, though the vagoglossopharyngeal variant (with associated cardiac events) requires urgent attention and treatment. For typical GPN, the natural history is variable — many patients experience periods of spontaneous remission. However, without treatment, severe pain attacks can profoundly impair quality of life, making it difficult to eat, drink, or speak. For patients well controlled on medication, conservative management is entirely appropriate. GPN does not cause permanent brain damage and does not shorten life expectancy.

References

Helpful links

Microvascular decompression (MVD) — procedure animation A short medical animation of how the operation works



Glossopharyngeal Neuralgia — patient information sheet PDF · prepared by Mr Jeremy Russell

Download PDF

Content on this page is for education and information only and is not a substitute for advice from your doctor. Medically reviewed by Mr Jeremy Russell.